The α4β7 blockade with vedolizumab is effective in prevention of graft vs. host disease using a xenogeneic mouse model

被引：2

作者：

Palaniyandi, Senthilnathan ^{[1
]}

Kumari, Reena ^{[1
]}

Strattan, Ethan ^{[1
,2
]}

Huang, Timothy ^{[1
]}

Du, Jing ^{[3
]}

Hakim, Natalya ^{[3
]}

Kesler, Melissa V. ^{[3
]}

Hildebrandt, Gerhard C. ^{[1
,2
]}

机构：

[1] Univ Kentucky, Dept Internal Med, Markey Canc Ctr, Div Hematol & Blood & Marrow Transplantat, Lexington, KY 40536 USA

[2] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA

[3] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2020年 / 95卷 / 02期

关键词：

T-CELLS; INTEGRIN; ANTIBODY;

D O I：

10.1002/ajh.25678

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E39 / E41

页数：3

共 10 条

[1] Expression of α4β7 integrin on memory CD8+ T cells at the presentation of acute intestinal GVHD [J].

Chen, Y-B ;

McDonough, S. ;

Chen, H. ;

Kennedy, J. ;

Illiano, C. ;

Attar, E. C. ;

Ballen, K. K. ;

Dey, B. R. ;

McAfee, S. L. ;

Jagasia, M. ;

Soiffer, R. ;

Spitzer, T. R. ;

Ritz, J. .

BONE MARROW TRANSPLANTATION, 2013, 48 (04) :598-603

[2] Role of CXCR3-induced donor T-cell migration in acute GVHD [J].

Duffner, U ;

Lu, B ;

Hildebrandt, GC ;

Teshima, T ;

Williams, DL ;

Reddy, P ;

Ordemann, R ;

Clouthier, SG ;

Lowler, K ;

Liu, C ;

Gerard, C ;

Cooke, KR ;

Ferrara, JLM .

EXPERIMENTAL HEMATOLOGY, 2003, 31 (10) :897-902

[3] Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease [J].

Floisand, Yngvar ;

Lundin, Knut E. A. ;

Lazarevic, Vladimir ;

Kristiansen, Jorn Dehli ;

Osnes, Liv T. N. ;

Tjonnfjord, Geir E. ;

Reims, Henrik Mikael ;

Gedde-Dahl, Tobias .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (01) :172-175

[4] The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation [J].

Hill, GR ;

Ferrara, JLM .

BLOOD, 2000, 95 (09) :2754-2759

[5] Target antigens determine graft-versus-host disease phenotype [J].

Kaplan, DH ;

Anderson, BE ;

McNiff, JM ;

Jain, D ;

Shlomchik, MJ ;

Shlomchik, WD .

JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5467-5475

[6] LPAM(α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease [J].

Petrovic, A ;

Alpdogan, O ;

Willis, LM ;

Eng, JM ;

Greenberg, AS ;

Kappel, BJ ;

Liu, C ;

Murphy, GJ ;

Heller, G ;

van den Brink, MRM .

BLOOD, 2004, 103 (04) :1542-1547

[7]

Picarella D, 1997, J IMMUNOL, V158, P2099

[8] The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases [J].

Soler, Dulce ;

Chapman, Tobias ;

Yang, Li-Li ;

Wyant, Tim ;

Egan, Robert ;

Fedyk, Eric R. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (03) :864-875

[9] A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- γc-/- double-mutant mice [J].

van Rijn, RS ;

Simonetti, ER ;

Hagenbeek, A ;

Hogenes, MCH ;

de Weger, RA ;

Canninga-van Dijk, MR ;

Weijer, K ;

Spits, H ;

Storm, G ;

van Bloois, L ;

Rijkers, G ;

Martens, ACM ;

Ebeling, SB .

BLOOD, 2003, 102 (07) :2522-2531

[10] An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab [J].

Wyant, Tim ;

Fedyk, Eric ;

Abhyankar, Brihad .

JOURNAL OF CROHNS & COLITIS, 2016, 10 (12) :1437-1444

← 1 →